Pro Medicus Limited PME.AX

Healthcare · Health Information Services · valued as of 2026-11-02 · statements 2026-06-30

Average Intrinsic Value
$220.46B
Market Cap
$11.51B
Margin of Safety
94.8%
Intrinsic / Market Ratio
19.15

How Each Value Is Built

The screener's three formulas on the reported figures. Each card reads the same way: the value as a sum of numbered terms, each term's calculation opened under it, from the reported figures to the value. The list ranks companies by their plain average over the market cap.

EPV + Growth

1.57B USD

what the normal year's earnings are worth for ever, plus growth that pays

Profit

15.78B USD

15 years of cash the shareholders can take out, and the equity left at year 15

FCFF

644.02B USD

15 years of cash for shareholders and lenders, less what is owed

Intrinsic Value

220.46B USD

the plain average of the three, uncapped, as the screener averages them

Intrinsic Value

220.46B USD

from the sum above

Market Cap

11.51B USD

today's price times the shares

Intrinsic Value ÷ Market Cap

19.15×

the ratio the screener ranks by; Margin of Safety +94.8% (1 − Market Cap ÷ Intrinsic Value)

Each card below builds one of the three values from the reported years.

Earnings power value plus growth: 1.57B USD
What the normal year's operating profit after tax is worth if it lasts for ever, plus what the new investment adds beyond its cost, less the net debt that comes before the shareholders (or plus the net cash).
①EPV (earnings power value)1.12B USD
+②Net Cash Today171.12M USD
+③Growth Value279.99M USD
=Value1.57B USD

EPV of the Operations (NOPAT over WACC)

1.12B USD

Net cash today

+171.12M USD

Growth Value

+279.99M USD

Value

1.57B USD

①EPV (earnings power value)

1.12B USD

②Net Cash Today

171.12M USD

③Growth Value

279.99M USD

Market value

Market Cap11.51B USD

Today's price times the shares.

Value vs market

Margin of Safety-631.2%

1 minus the market cap as a share of the value.

Profit value: today's value of the shareholders' equity, from the cash it can pay them (FCFE): 15.78B USD
Fifteen years of free cash flow to equity (FCFE), each brought to today at the cost of equity, plus the equity at year 15 brought to today.
①Present Value of the 15 Years of FCFE11.31B USD
+②Equity at Year 15, Today4.47B USD
=Value15.78B USD
FCFE: the net income left for the shareholders once the business keeps what next year's growth needsEquity reinvestment: the part of the year's net income kept in the business to grow the next year; below zero, capital the business releases to the shareholdersPresent value of the FCFEColoured bars show the FCFE, grey bars the equity reinvestment. With a positive equity reinvestment the two stacked are the year's normalized income; with a negative one the grey is below zero, capital the business releases, and the normalized income is the FCFE plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROE on new investment falling to the cost of equity. Axes linear.

①Present Value of the 15 Years of FCFE

11.31B USD

②Equity at Year 15, Today

4.47B USD

Market value

Market Cap11.51B USD

Today's price times the shares.

Value vs market

Margin of Safety+27.0%

1 minus the market cap as a share of the value.

FCFF value: today's value of the shareholders' equity, from the cash the firm can pay its shareholders and lenders (FCFF): 644.02B USD
Fifteen years of free cash flow to the firm (FCFF), each brought to today at the WACC, plus the invested capital at year 15 brought to today, less the net debt today (or plus the net cash).
①Present Value of the 15 Years of FCFF487.91B USD
+②Invested Capital at Year 15, Today155.93B USD
+③Net Cash Today171.12M USD
=Value644.02B USD
FCFF: the NOPAT left for the shareholders and the lenders once the business reinvests what next year's growth needsReinvestment: the part of the year's NOPAT put back into the business to grow the next year; below zero, capital the business releasesPresent value of the FCFFColoured bars show the FCFF, grey bars the reinvestment. With a positive reinvestment the two stacked are the year's NOPAT; with a negative one the grey is below zero, capital the business releases, and the NOPAT is the FCFF plus that negative amount. Shaded, years 6 to 10: the growth falling to its long-run rate and the ROIC on new investment falling to the WACC. Axes linear.

①Present Value of the 15 Years of FCFF

487.91B USD

②Invested Capital at Year 15, Today

155.93B USD

③Net Cash Today

171.12M USD

Market value

Market Cap11.51B USD

Today's price times the shares.

Value vs market

Margin of Safety+98.2%

1 minus the market cap as a share of the value.

The Rates and the Capital the Values Read

The WACC and the cost of equity each value is discounted at, the book value and the net debt each starts from, and the seven quality metrics, from the same run.

WACC: 7.98%
weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.
Cost of Equity =Risk-Free Rate 4.50%+Beta 0.58×Market Risk Premium 6.00%= 7.98%

The yearly return the shareholders require for the risk they carry; it is the rate that brings their future cash to today.

Tax Rate for WACC =Tax Provision 77.28M USDPretax Income 260.08M USD= 29.71%

The tax the interest saves.

Interest Expense =EBIT 135.06M USD−Pretax Income 260.08M USD= —

The interest the company paid: EBIT is the profit before tax plus the interest.

No interest is read: it needs debt and an EBIT above the profit before tax, the gap between them being the interest. Without it the cost of debt takes the 4% default.

Cost of Debt 4.00% (default): with no debt or no interest read, the 4% default after tax stands for what the lenders are paid a year.

Debt Weight =Total Debt 1.54M USDMarket Cap + Total Debt 11.51B USD + 1.54M USD= 0.01%

The part of the capital the lenders put in, at market value.

WACC =Equity Weight 99.99%×Cost of Equity 7.98%+Debt Weight 0.01%×Cost of Debt 4.00%= 7.98%

Weighted average cost of capital: the yearly return the shareholders and the lenders together require, weighted by what each puts in; the rate that brings the firm's future cash to today.

Book value and net debt today
Both from the balance sheet of the newest quarter, 2026-06-30.

Total Assets 420.34M USD − Total Liabilities 109.69M USD = Book Value Today 310.65M USD

Total Debt 1.54M USD − Cash and Short-Term Investments 172.66M USD = Net Debt Today -171.12M USD

The book value is what Profit starts from and what stands when a projection is not made; the book value plus the net debt is what FCFF starts from; the net debt comes off Greenwald's and FCFF's values before the shareholders.

Quality metrics
Read beside the value, never a condition for it: every company is valued, and a filter in the list is the reader's choice.
MetricFrom
Share dilutionShares Today ÷ Shares Two Years Back − 10.0%at most 5%passes104,469,963 / 104,424,882
Accrual quality(Operating Cash Flow − Net Income) ÷ Total Assets—at least -10.0%not measured(— − 182.80M USD) ÷ 420.34M USD
Price to bookMarket Cap ÷ Book Value Today37.05×at most 3×does not pass11.51B USD ÷ 310.65M USD
Operating marginOperating Income ÷ Revenue74.9%above 10.0%passes135.06M USD ÷ 180.23M USD
Revenue growthRevenue ÷ Revenue a Year Before − 129.4%above 10.0%passes180.23M USD / 139.23M USD
Net cash(Cash − Total Debt) ÷ Market Cap1.3%above -30%passes(148.90M USD − 1.54M USD) ÷ 11.51B USD
Operating efficiencyOperating Income ÷ Gross Profit75.1%above 25.0%passes135.06M USD ÷ 179.96M USD

Market Data

The provider's ratios and the analysts' consensus beside the argument; none of them enters a value.

Market data
The data provider's own ratios and the analysts' consensus, read beside the valuation, never in it.

Share price

157 USD

Enterprise value

16.10B USD

market cap plus net debt

EV / EBITDA

81.87×

Price / book

36.23×

the provider's book

Price / earnings

61.81×

Return on equity

75.0%

the provider's, not the engine's

Profit margin

101.4%

Revenue growth

18.2%

Analyst target, mean

203 USD

Analysts

15

opinions in the consensus

Financial Statements

The income statement, the balance sheet and the cash flow the screener holds, year by year, in USD.

Financial statements, year by year
The annual lines the screener holds today, in USD at each period's rate; the figures this valuation read are in its calculation above.
USD2023202420252026
Income statement

Revenue

82.69M107.47M139.23M180.23M

Gross profit

82.33M107.27M139.03M179.96M

Operating income

55.50M74.68M103.08M135.06M

EBITDA

operating income before depreciation and amortisation

60.75M80.35M107.81M140.61M

Pretax income

57.07M77.56M106.80M260.08M

Net income

40.19M55.12M75.35M182.80M

Normalized income

net income without one-off items, as the data provider prints it; Profit's line when printed

40.19M55.12M75.35M182.80M

R&D

————
Balance sheet, year end

Total assets

133.94M171.73M221.50M420.34M

Total liabilities

41.98M46.40M53.46M109.69M

Shareholders' equity

the equity the parent's shareholders own, as printed, without minority interest; the book value the values read is total assets less total liabilities, in Book Value and Net Debt above

91.96M124.98M168.05M310.65M

Total debt

1.23M1.38M1.47M1.54M

Cash and equivalents

60.46M82.50M114.14M148.90M

Net PP&E

fixed assets after depreciation

1.45M1.58M1.81M1.92M

Working capital

current assets less current liabilities

88.09M114.86M154.96M210.62M
Cash flow

Operating cash flow

————

Capital expenditure

paid out, so below zero

-4.27M-4.46M-4.82M-5.98M

Depreciation and amortisation

5.25M5.67M4.73M5.55M

Free cash flow

operating cash flow plus capital expenditure

37.17M50.12M67.98M81.84M